Glottis ₹307 crore IPO opens September 29; anchor investors commit ₹55.3 crore ahead of listing
Glottis BioPharma Ltd is set to launch its ₹307 crore Initial Public Offering (IPO) on September 29, 2025, marking a major milestone for the fast-growing pharmaceutical and biotech firm. The IPO will remain open for subscription until October 3, with a price band expected to be announced shortly. Ahead of the public offering, Glottis has…